Life-science briefing: Tuesday, April 8, 2008

Life-science briefing: Tuesday, April 8, 2008

TODAY’S HEADLINES:

AGI Dermatics takes in $5M for skincare products (release)
Myconostica raises £3.9 for fungal diagnostics (GenomeWeb)

Germany’s Noxxon gets €1M grant for aptamer drugs (release)

AGI Dermatics takes in $5M for skincare products – Freeport, N.Y.-based AGI Dermatics, a startup concentrated on skincare products, raised $5 million in a new funding round. Investors included Trevi Health Ventures and Spring Mountain Capital.

AGI makes cosmetic ingredients and is working on developing topical pharmaceutical lotions as well. Its leading drug candidate… Continue Reading

Life sciences briefing: Wednesday, Oct. 17, 2007

Life sciences briefing: Wednesday, Oct. 17, 2007

Featured companies: Algorithme Pharma, Bacchus Vascular, Botaneco, Cubist Pharmaceuticals, Ikonisys, Healthcare Management Systems, Illumigen Biosciences, Kilmer Capital Partners, Medical Specialties Distributors, Metastatix, Microphage, Orthosoft, Thomas McNerney & Partners, TranS1, TriReme Medical, Wren Medical, Zimmer

UPDATE: Expanded TriReme Medical, Ikonisys and TranS1 items.

UPDATE REDUX: Added MicroPhage item.

Stent-maker TriReme Medical sails off with $15.6M — Pleasanton, Calif.-based TriReme Medical, a device maker developing a new type of artery-opening stent for blood-vessel junctions, raised $15.6 million in a third funding… Continue Reading

Optovue, an ocular disease treatment co., raises $10.5M

Optovue, a Fremont, Ca. maker of devices that improve diagnosis and treatment of ocular disease, has received $10.5 million in second round of funding, the company announced said.

Based on high speed and high resolution Fourier-Domain OCT technology, the products help with retina conditions such as macular degeneration, diabetic retinopathy, glaucoma, and other macular diseases.

Trevi Health Ventures led the round, which also included Acorn Campus Ventures, HNQ Asia Pacific, Harbinger Venture Management, iD SoftCapital and other… Continue Reading